# Dopamine Effect on Inhibitory Control

> **NCT03665493** · NA · COMPLETED · sponsor: **Giovanni Mirabella** · enrollment: 90 (actual)

## Conditions studied

- Idiopathic Parkinson's Disease

## Interventions

- **DRUG:** PD patients H&Y=1.5-2 Medications ON
- **DRUG:** PD patients H&Y=1.5-2 Medications OFF
- **BEHAVIORAL:** Healthy age-matched controls
- **DRUG:** PD patients H&Y=3 Medications OFF
- **DRUG:** PD patients H&Y=3 Medications ON

## Key facts

- **NCT ID:** NCT03665493
- **Lead sponsor:** Giovanni Mirabella
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-30
- **Primary completion:** 2023-01-20
- **Final completion:** 2023-11-10
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03665493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03665493, "Dopamine Effect on Inhibitory Control". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03665493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*